Understanding the role patient subtype plays in PsA treatment selection
Understanding the drivers of treatment choice in the real world to see if certain patient subtypes see greater use of specific, competitive treatments and which are favored for lines of therapy.
Leverage OM1 linked clinical EMR and claims data along with PROs and ClinROs; Create patient severity subtypes using CDAI and RAPID 3 scores
PsA patients followed longitudinally with deep clinical data
of patients w/ at least 1 CDAI score
of patients w/ at least 1 RAPID 3 score